Table 2.

Commencement of venom immunotherapy (VIT) and the status with regard to diagnostic testing, diagnoses, information regarding VIT of patients who did not begin VIT, and reasons given for not starting VIT

Patient population (n = 126)	No. (%)
Currently receiving VIT	16 (13)
Completed VIT	38 (30)
Started but did not finished VIT	8 (6)
Will start VIT	1 (1)
No answer	1 (1)
No VIT	62 (49)
Patients not starting VIT (n = 62)	No. (%)
Did not receive diagnostics, received information	5 (8)
Did not receive diagnostics, did not receive information	27 (44)
Diagnosed with HVA, received information	14 (23)
Diagnosed with HVA, did not receive information	6 (10)
Other	8 (13)
Reason given by patients for not starting VIT	No.
Unnecessary	3
Not interested	2
Only had one reaction	5
Not an option	1
Too much effort	4
Takes too long	3
Did not want to be hospitalized	1
Expensive	1
Risk to high	2
Not effective	2
Have heard about negative experiences	2

HVA Hymenoptera venom anaphylaxis